A world leader in endoluminal treatment of aortic disease discusses the evolution of TAA grafting and the Zilver PTX trial.
By Michael D. Dake, MD
A novel treatment approach for renal cell carcinoma, with potential benefits of cost saving and reduction of postinfarction syndrome.
By Peter H. Lin, MD; Ruth L. Bush, MD; Andres Eraso, MD; and Wei Zhou, MD
By Michael L. Censullo, MD; Polina N. Kyriakides, MD; Lucho L. Rossman, MD; and Alan M. Cohen, MD
The advent of endovascular techniques and devices has led to this procedure becoming the standard of care for most patients prior to surgical resection.
By Robert B. McLafferty, MD
Transarterial interventions continue to play a key role in managing patients with hepatic malignancy.
By Michael J. Wallace, MD, and Ravi Murthy, MD
A method to improve the safety of major hepatic resection.
By David C. Madoff, MD
Endovascular treatment of this patient population has been shown to be effective.
By Robert L. Hynecek, MD; Brian G. DeRubertis, MD; Rabih A. Chaer, MD;K. Craig Kent, MD; and Peter L. Faries, MD
Advances in embolic agents and microcatheter techniques have allowed more successful treatment of this uncommon clinical entity.
By Wei Zhou, MD; Peter H. Lin, MD; Andres Eraso, MD; and Alan B. Lumsden, MD
Current issues in the regulation of IVC filters.
By Angela C. Smith and Dorothy B. Abel
By Peter H. Lin, MD, Michael J. Wallace, MD
An update on inaugural testing in the ABVM.